Cargando…

TIM-3 expression in breast cancer

Tumor-infiltrating lymphocytes (TILs) are predominantly present in breast cancer patients with estrogen receptor negative tumors, among whom increasing levels correlate with favorable outcomes. Nevertheless, currently available immune checkpoint inhibitors appear to benefit only a small number of wo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burugu, Samantha, Gao, Dongxia, Leung, Samuel, Chia, Stephen K., Nielsen, Torsten O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205019/ https://www.ncbi.nlm.nih.gov/pubmed/30377566 http://dx.doi.org/10.1080/2162402X.2018.1502128

Ejemplares similares

Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
por: Riaz, Nazia, et al.
Publicado: (2021)

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
por: Cheng, Angela S., et al.
Publicado: (2019)

Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints
por: Chafe, Shawn C., et al.
Publicado: (2021)

Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration
por: Liu, Shuzhen, et al.
Publicado: (2014)

CD8(+ )lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
por: Liu, Shuzhen, et al.
Publicado: (2012)

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
por: Stovgaard, Elisabeth S, et al.
Publicado: (2021)

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2013)

Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer
por: Asleh, Karama, et al.
Publicado: (2021)

On the significance of Tim-3 expression in pancreatic cancer
por: Peng, Pu-ji, et al.
Publicado: (2017)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
por: Cheang, Maggie C. U., et al.
Publicado: (2009)

Dysregulated T cell expression of TIM3 in multiple sclerosis
por: Koguchi, Ken, et al.
Publicado: (2006)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
por: Bruss, Christina, et al.
Publicado: (2023)

Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis
por: Wang, Yaping, et al.
Publicado: (2020)

TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
por: Gao, Xin, et al.
Publicado: (2012)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

Tim-3 Expression Defines Regulatory T Cells in Human Tumors
por: Yan, Jing, et al.
Publicado: (2013)

Association of TIM-3 expression with glucose metabolism in Jurkat T cells
por: Lee, Mi Jin, et al.
Publicado: (2020)

Tim-3 expression and its role in hepatocellular carcinoma
por: Liu, Feifei, et al.
Publicado: (2018)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients
por: Wang, Yong, et al.
Publicado: (2016)

The Tim54p–Tim22p Complex Mediates Insertion of Proteins into the Mitochondrial Inner Membrane
por: Kerscher, Oliver, et al.
Publicado: (1997)

Immune regulation by Tim-3
por: Banerjee, Hridesh, et al.
Publicado: (2018)

Polymorphisms in TIM-3 and breast cancer susceptibility in Chinese women: A case-control study
por: Wang, Zheng, et al.
Publicado: (2016)

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
por: Gonçalves Silva, Isabel, et al.
Publicado: (2016)

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2021)

Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression
por: Tromp, Samantha A.M., et al.
Publicado: (2022)

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
por: Yasinska, Inna M., et al.
Publicado: (2019)

Quantitative assessment of TIM-3 polymorphisms and cancer risk in Chinese Han population
por: Gao, Xueren, et al.
Publicado: (2016)

Divergent Small Tim Homologues Are Associated with TbTim17 and Critical for the Biogenesis of TbTim17 Protein Complexes in Trypanosoma brucei
por: Smith, Joseph T., et al.
Publicado: (2018)

TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer
por: Kato, Renpei, et al.
Publicado: (2020)

TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
por: Jayaraman, Pushpa, et al.
Publicado: (2016)

Dok-3 deficient mice display different immune clustering and Tim-3 expression
por: Yan, Wenjiang, et al.
Publicado: (2019)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
por: Jiang, Jing, et al.
Publicado: (2013)

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
por: Cai, Letong, et al.
Publicado: (2023)

Phospho-Ser(784)-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer
por: Zhu, Cuige, et al.
Publicado: (2020)

TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target
por: Palacios, Luz Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_do9969ba474hiehalspq54klu6